Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Oleksandr Varunkiv (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Oleksandr Varunkiv, Mariana Kulynych-Miskiv, Iryna Savelikhina. Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels. Eur Respir J 2015; 46: Suppl. 59, 4001

Member's Comments

No comment yet.

Related content which might interest you: Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exhaled nitric oxide in diagnosis and management of respiratory diseases Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Diagnostic value of FeNO in COPD and asthma - COPD overlap syndrome Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Temporal stability of feno measurement in COPD Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma Year: 2015 Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma Source: Eur Respir J 2006; 27: 951-956 Year: 2006 Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Prevalence and relationship of hypomagnesiemia with children bronchial asthma control Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013 Noninvasive assessment of inflammation in severe asthma Source: Eur Respir Mon 2011; 51: 208-217 Year: 2011 Diagnosing asthma and prognostic significance of eNO Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005 Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001